The treatment gap in patients with chronic systolic heart failure: a systematic review of evidence-based prescribing in practice

Heart Failure Reviews

Volumn 21, Issue 6, 2016, Pages 675-697

  Chin, Ken Lee ^a,b   Skiba, Marina ^a,b   Tonkin, Andrew ^a   Reid, Christopher M ^a,c   Liew, Danny ^a   Krum, Henry ^a,b   Hopper, Ingrid ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b ALFRED HOSPITAL   (Australia)

^c CURTIN UNIVERSITY   (Australia)

Author keywords

Registry; Survey; Systolic heart failure; Treatment gap

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MINERALOCORTICOID ANTAGONIST;

AGE; COMORBIDITY; DISEASE ASSOCIATION; DRUG USE; EVIDENCE BASED PRACTICE; HEALTH CARE AVAILABILITY; HEART FAILURE WITH REDUCED EJECTION FRACTION; HUMAN; MORTALITY RISK; PRESCRIPTION; RECOMMENDED DRUG DOSE; REVIEW; SEX DIFFERENCE; SYSTEMATIC REVIEW; SYSTOLIC HEART FAILURE; TREATMENT GAP; TREATMENT OUTCOME; CHRONIC DISEASE; CLINICAL PRACTICE; EVIDENCE BASED MEDICINE; HEART STROKE VOLUME; PROTOCOL COMPLIANCE; STATISTICS AND NUMERICAL DATA;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CHRONIC DISEASE; EVIDENCE-BASED MEDICINE; GUIDELINE ADHERENCE; HEART FAILURE, SYSTOLIC; HUMANS; MINERALOCORTICOID RECEPTOR ANTAGONISTS; PRACTICE PATTERNS, PHYSICIANS'; STROKE VOLUME;

EID: 84980021875     PISSN: 13824147     EISSN: 15737322     Source Type: Journal    
DOI: 10.1007/s10741-016-9575-2     Document Type: Review

References (63)

1. Krum H, Abraham WT (2009) Heart failure. Lancet 373:941–955
2. McMurray JJV, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Køber L, Lip GYH, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Rønnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33:1787–1847
3. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey J, Donald E, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJV, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WHW, Tsai EJ, Wilkoff BL (2013) 2013 ACCF/AHA Guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 128:e240–e327
4. Komajda M, Lapuerta P, Hermans N, Gonzalez-Juanatey JR, van Veldhuisen DJ, Erdmann E, Tavazzi L, Poole-Wilson P, Le Pen C (2005) Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey. Eur Heart J 26(16):1653–1659. doi:10.1093/eurheartj/ehi251
5. Poelzl G, Altenberger J, Pacher R, Ebner CH, Wieser M, Winter A, Fruhwald F, Dornaus C, Ehmsen U, Reiter S, Steinacher R, Huelsmann M, Eder V, Boehmer A, Pilgersdorfer L, Ablasser K, Keroe D, Groebner H, Auer J, Jakl G, Hallas A, Ess M, Ulmer H (2014) Dose matters! Optimisation of guideline adherence is associated with lower mortality in stable patients with chronic heart failure. Int J Cardiol 175(1):83–89. doi:10.1016/j.ijcard.2014.04.255
6. Komajda M (2009) How well are we implementing evidence-based care? Eur J Heart Failure Suppl 8:i39–i44
7. Teng T-HK, Hung J, Knuiman M, Stewart S, Arnolda L, Jacobs I, Hobbs M, Sanfilippo F, Geelhoed E, Finn J (2012) Trends in long-term cardiovascular mortality and morbidity in men and women with heart failure of ischemic versus non-ischemic aetiology in Western Australia between 1990 and 2005. Int J Cardiol 158:405–410
8. Lainščak M, Cleland JG, Lenzen MJ, Follath F, Komajda M, Swedberg K (2007) International variations in the treatment and co-morbidity of left ventricular systolic dysfunction: data from the EuroHeart Failure Survey. Eur J Heart Fail 9(3):292–299
9. Yancy CW, Fonarow GC, Albert NM, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, McBride ML, Mehra MR, O’Connor CM, Reynolds D, Walsh MN (2009) Influence of patient age and sex on delivery of guideline-recommended heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF. Am Heart J 157(4):754–762e752
10. The Study Group on Diagnosis of the Working Group on Heart Failure of The European Society of Cardiology (1999) Increasing awareness and improving the management of heart failure in Europe: the IMPROVEMENT of HF initiative. Eur J Heart Fail 1:139–144
11. Forman DE, Cannon CP, Hernandez AF, Liang L, Yancy C, Fonarow GC (2009) Influence of age on the management of heart failure: findings from Get With the Guidelines-Heart Failure (GWTG-HF). Am Heart J 157(6):1010–1017
12. Fonarow GC, Abraham WT, Albert NM, Gattis WA, Gheorghiade M, Greenberg B, O’Connor CM, Yancy CW, Young J (2004) Organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF): rationale and design. Am Heart J 148:43–51
13. Sharma A, Ezekowitz JA (2013) Similarities and differences in patient characteristics between heart failure registries versus clinical trials. Curr Heart Fail Rep 10(4):373–379. doi:10.1007/s11897-013-0152-x
14. Reid CM (2015) The role of clinical registries in monitoring drug safety and efficacy. Heart Lung Circ 24:1049–1052
15. Moher D, Liberati A, Tetzlaff J, Altman DG, and the PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Ann Intern Med 151:264–269
16. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA Statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 151:W-65–W-94
17. Störk S, Hense HW, Zentgraf C, Uebelacker I, Jahns R, Ertl G, Angermann CE (2008) Pharmacotherapy according to treatment guidelines is associated with lower mortality in a community-based sample of patients with chronic heart failure: a prospective cohort study. Eur J Heart Fail 10:1236–1245
18. Kim SY, Park JE, Lee YJ, Seo H-J, Sheen S-S, Hahn S, Jang B-H, Son H-J (2013) Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity. J Clin Epidemiol 66:408–414
19. Ziff OJ, Lane DA, Samra M, Griffith M, Kirchhof P, Lip GYH, Steeds RP, Townend J, Kotecha D (2015) Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data. BMJ 351:h4451
20. Song HJ, Son H, Seo H-J, Lee H, Choi SM, Lee S (2015) Effect of self-administered foot reflexology for symptom management in healthy persons: a systematic review and meta-analysis. Complement Ther Med 23:79–89
21. William JF, Bristow MR, Fowler MB, Francis GS, Garson A Jr, Gersh BJ, Hammer DF, Hlatky MA, Leier CV, Packer M, Pitt B, Ullyot DJ, Wexler LF, Winters WL (1995) Guidelines for the evaluation and management of heart failure. J Am Coll Cardiol 26:1376–1398
22. Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, Ganiats TG, Goldstein S, Gregatos G, Jessup ML, Noble RJ, Packer M, Silver MA, Stevenson LW (2001) ACC/AHA Guidelines for the evaluation and management of chronic heart failure in the adult—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee to revise the 1995 guidelines for the evaluation and management of heart failure). Circulation 104:2996–3007
23. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam M, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW (2005) ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 46(6):e1–82
24. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam M, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW (2009) 2009 Focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 119:e391–e479
25. Task Force for the Diagnosis and Treatment of Chronic Heart Failure ESoC (2001) Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 22:1527–1560
26. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, Tavazzi L, Smiseth OA, Gavazzi A, Haverich A, Hoes A, Jaarsma T, Korewicki J, Lévy S, Linde C, Lopez-Sendon J-L, Nieminen MS, Piérard L, Remme WJ (2005) Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): the Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 26:1115–1140
27. Dickstein K, Cohen Solal A, Filippatos G, McMurray JJV, Ponikowski P, Poole-Wilson PA, Strömberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K (2008) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29:2388–2442
28. Heywood JT, Fonarow GC, Yancy CW, Albert NM, Curtis AB, Gheorghiade M, Inge PJ, McBride ML, Mehra MR, O’Connor CM, Reynolds D, Walsh MN (2010) Comparison of medical therapy dosing in outpatients cared for in cardiology practices with heart failure and reduced ejection fraction with and without device therapy: report from IMPROVE HF. Circ Heart Fail 3(5):596–605. doi:10.1161/circheartfailure.109.912683
29. McKee SP, Leslie SJ, LeMaitre JP, Webb DJ, Denvir MA (2003) Management of chronic heart failure due to systolic left ventricular dysfunction by cardiologist and non-cardiologist physicians. Eur J Heart Fail 5(4):549–555
30. Lenzen MJ, Boersma E, Scholte op Reimer WJM, Balk AHMM, Komajda M, Swedberg K, Follath F, Jimenez-Navarro M, Simoons ML, Cleland JGF (2005) Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure. Eur Heart J 26:2706–2713
31. Anguita M, Comin-Colet J, Formiga F, Almenar L, Crespo-Leiro M, Manzano L, on behalf of the investigators of the VIDA–IC Study (2014) Current situation of management of systolic heart failure in Spain: VIDA–IC Study results. Rev Esp Cardiol 67(9):769–770
32. Cohen Solal A, Leurs I, Assyag P, Beauvais F, Clerson P, Contre C, Thebaut J-F, Genoun M, in collaboration with the French National College of Cardiologists (2012) Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey. Arch Cardiovasc Dis 105(6–7):355–365. doi:10.1016/j.acvd.2012.04.003
33. de Groote P, Isnard R, Assyag P, Clerson P, Ducardonnet A, Galinier M, Jondeau G, Leurs I, Thebaut JF, Komajda M (2007) Is the gap between guidelines and clinical practice in heart failure treatment being filled? Insights from the IMPACT RECO survey. Eur J Heart Fail 9(12):1205–1211. doi:10.1016/j.ejheart.2007.09.008
34. de Groote P, Isnard R, Clerson P, Jondeau G, Galinier M, Assyag P, Demil N, Ducardonnet A, Thebaut JF, Komajda M (2009) Improvement in the management of chronic heart failure since the publication of the updated guidelines of the European Society of Cardiology. The Impact-Reco Programme. Eur J Heart Fail 11(1):85–91. doi:10.1093/eurjhf/hfn005
35. Fonarow GC, Yancy CW, Albert NM, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, McBride ML, Mehra MR, O’Connor CM, Reynolds D, Walsh MN (2008) Heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF. Circ Heart Fail 1(2):98–106
36. Franke J, Zugck C, Wolter JS, Frankenstein L, Hochadel M, Ehlermann P, Winkler R, Nelles M, Zahn R, Katus HA, Senges J (2012) A decade of developments in chronic heart failure treatment: a comparison of therapy and outcome in a secondary and tertiary hospital setting. Clin Res Cardiol 101(1):1–10. doi:10.1007/s00392-011-0348-6
37. Frankenstein L, Remppis A, Fluegel A, Doesch A, Katus HA, Senges J, Zugck C (2010) The association between long-term longitudinal trends in guideline adherence and mortality in relation to age and sex. Eur J Heart Fail 12(6):574–580. doi:10.1093/eurjhf/hfq047
38. Goldberg RJ, Gurwitz JH, Saczynski JS, Hsu G, McManus DD, Magid DJ, Smith DH, Go AS (2013) Comparison of medication practices in patients with heart failure and preserved versus those with reduced ejection fraction (from the Cardiovascular Research Network [CVRN]). Am J Cardiol 111(9):1324–1329. doi:10.1016/j.amjcard.2013.01.276
39. Hebert K, Dias A, Delgado MC, Franco E, Tamariz L, Steen D, Trahan P, Major B, Arcement LM (2010) Epidemiology and survival of the five stages of chronic kidney disease in a systolic heart failure population. Eur J Heart Fail 12(8):861–865. doi:10.1093/eurjhf/hfq077
40. Heywood JT, Fonarow GC, Yancy CW, Albert NM, Curtis AB, Stough WG, Gheorghiade M, McBride ML, Mehra MR, O’Connor CM, Reynolds D, Walsh MN (2010) Influence of renal function on the use of guideline-recommended therapies for patients with heart failure. Am J Cardiol 105(8):1140–1146. doi:10.1016/j.amjcard.2009.12.016
41. Lenzen MJ, Rosengren A, Scholte op Reimer WJ, Follath F, Boersma E, Simoons ML, Cleland JG, Komajda M (2008) Management of patients with heart failure in clinical practice: differences between men and women. Heart (British Cardiac Society) 94(3):e10. doi:10.1136/hrt.2006.099523
42. Lenzen MJ, Scholte op Reimer WJ, Boersma E, Vantrimpont PJ, Follath F, Swedberg K, Cleland J, Komajda M (2004) Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey. Eur Heart J 25(14):1214–1220. doi:10.1016/j.ehj.2004.06.006
43. Loh JC, Creaser J, Rourke DA, Livingston N, Harrison TK, Vandenbogaart E, Moriguchi J, Hamilton MA, Tseng CH, Fonarow GC, Horwich TB (2013) Temporal trends in treatment and outcomes for advanced heart failure with reduced ejection fraction from 1993–2010: findings from a university referral center. Circ Heart Fail 6(3):411–419
44. Schneider PM, Pellegrini CN, Wang Y, Fein AS, Reynolds MR, Curtis JP, Masoudi FA, Varosy PD (2014) Prevalence of guideline-directed medical therapy among patients receiving cardiac resynchronization therapy defibrillator implantation in the National Cardiovascular Data Registry during the years 2006 to 2008. Am J Cardiol 113(12):2052–2056. doi:10.1016/j.amjcard.2014.03.049
45. Scrutinio D, Passantino A, Santoro D, Catanzaro R (2011) The cardiorenal anaemia syndrome in systolic heart failure: prevalence, clinical correlates, and long-term survival. Eur J Heart Fail 13(1):61–67. doi:10.1093/eurjhf/hfq167
46. Shah DD, Fonarow GC, Horwich TB (2010) Metformin therapy and outcomes in patients with advanced systolic heart failure and diabetes. J Cardiac Fail 16(3):200–206. doi:10.1016/j.cardfail.2009.10.022
47. Stålhammar J, Stern L, Linder R, Sherman S, Parikh R, Ariely R, Wikström G (2012) Resource utilization and cost of heart failure associated with reduced ejection fraction in Swedish patients. J Med Econ 15(5):938–946
48. von Scheidt W, Zugck C, Pauschinger M, Hambrecht R, Bruder O, Hartmann A, Rauchhaus M, Zahn R, Brachmann J, Tebbe U, Neumann T, Strasser RH, Bohm M, Stork S, Hochadel M, Heidemann P, Senges J (2014) Characteristics, management modalities and outcome in chronic systolic heart failure patients treated in tertiary care centers: results from the EVIdence based TreAtment in Heart Failure (EVITA-HF) registry. Clin Res Cardiol 103(12):1006–1014
49. Cleland JG, Cohen-Solal A, Aguilar JC, Dietz R, Eastaugh J, Follath F, Freemantle N, Gavazzi A, van Gilst WH, Hobbs FD, Korewicki J, Madeira HC, Preda I, Swedberg K, Widimsky J, Committees IoHFP, Investigators, Improvement programme in e, management, Study Group on Diagnosis of the Working Group on Heart Failure of The European Society of C (2002) Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet 360(9346):1631–1639
50. Shiba N, Nochioka K, Miura M, Haruka K, Shimokawa H, on behalf of the CHART-2 Investigators (2011) Trend of westernization of etiology and clinical characteristics of heart failure patients in Japan: first report from the CHART-2 study. Circ J 75:823–833
51. Sturm HB, Haaijer-Ruskamp FM, Veeger NJ, Balje-Volkers CP, Swedberg K, van Gilst WH (2006) The relevance of comorbidities for heart failure treatment in primary care: a European survey. Eur J Heart Fail 8(1):31–37. doi:10.1016/j.ejheart.2005.03.010
52. Sturm HB, van Gilst WH, Veeger N, Haaijer-Ruskamp FM (2007) Prescribing for chronic heart failure in Europe: does the country make the difference? a European survey. Pharmacoepidemiol Drug Saf 16(1):96–103. doi:10.1002/pds.1216
53. Bonow RO, Gheorghiade M (2014) Performance matters in heart failure. JACC 63(2):131–132
54. Erhardt L, Komajda M, Hobbs FDR, Soler-Soler J (2008) Cardiologists’ awareness and perceptions of guidelines for chronic heart failure. The ADDress your Heart survey. Eur J Heart Fail 10:1020–1025
55. van der Wal MHL, Jaarsma T (2008) Adherence in heart failure in the elderly: problem and possible solutions. Int J Cardiol 158:203–208
56. Wu J-R, Moser DK, Lennie TA, Peden AR, Chen Y-C, Heo S (2008) Factors influencing medication adherence in patients with heart failure. Heart Lung 37:8–16
57. Safford MM, Shewchuk R, Qu H, Williams JH, Estrada CA, Ovalle F, Allison JJ (2007) Reasons for not intensifying medications: differentiating “clinical inertia” from appropriate care. J Gen Intern Med 22(12):1648–1655
58. Remme WJ (2007) Filling the gap between guidelines and clinical practice in heart failure treatment—still a far cry from reality. Eur J Heart Fail 9:1143–1145
59. Dokainish H, Teo K, Zhu J, Roy A, Al-Habib K, ElSayed A, Palileo L, Jaramillo PL, Karaye K, Yusoff K, Orlandini A, Sliwa K, Mondo C, Lanas F, Dorairaj P, Huffman M, Badr A, Elmaghawry M, Damasceno A, Belley-Cote E, Harkness K, Grinvalds A, McKelvie R, Yusuf S (2015) Heart failure in low- and middle-income countries: background, rationale, and design of the INTERnational Congestive Heart Failure Study (INTER-CHF). Am Heart J 170(627–634):e621
60. Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R, Fonseca V, Gerstein HC, Grundy S, Nesto RW, Pignone MP, Plutzky J, Porte D, Redberg R, Stitzel KF, Stone NJ (2007) Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation 115:114–126
61. Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EAM, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS (2009) Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association. J Am Coll Cardiol 53:298–304
62. Driscoll A, Krum H, Wolfe R, Tonkin A, on behalf of The Bench Study Group (2011) Nurse-led titration of ß-adrenoreceptor blocking agents in chronic heart failure patients in the community. J Cardiac Fail 17:224–230
63. Milfred-Laforest SK, Chow SL, Didomenico RJ, Dracup K, Ensor CR, Gattis-Stough W, Heywood JT, Lindenfeld J, Page RL II, Patterson JH, Vardeny O, Massie BM (2013) Clinical pharmacy services in heart failure: an opinion paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network. J Cardiac Fail 19(5):354–369